Junji Bio

Suzhou, China · Founded 2020 · Privately Held (backing)

Developer of biosynthesis designed to provide overall solutions for molecular diagnosis, nucleic acid chemistry, synthetic biology and antibody drug development. Junji Bio is based in Suzhou, China and was founded in 2020. It has raised $14.1 million.

Last price · $/share

—

Implied valuation

—

Total raised

$14.1M

Last round

—

How much has Junji Bio raised?

$14.1Macross 0 recorded rounds

Free account

More of Junji Bio with a free account

·Watch Junji Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Junji Bio investors

5 investors are on record for Junji Bio, including Hangzhou Dongfang Jiafu Asset Management, Optics Valley Industry Investment, Lianyungang Jinhai Venture Capital and Jiangsu Jinqiao Private Equity Fund Management.

For fundraisers

Raising for a company like Junji Bio?

5 investors have backed Junji Bio.

See all 5 investors →

Frequently asked about Junji Bio

How much has Junji Bio raised?: Junji Bio has raised $14.1M in total across 0 recorded funding rounds.